Latest

Metropolis provided a business update for the quarter ended March 31, 2025, indicating a subdued performance in the healthcare industry, particularly in the acute testing segment due to weather changes and lower elective procedures. Despite these challenges, the company achieved approximately 10% year-on-year revenue growth, driven by patient and test volume increases, with B2C revenues growing around 14%. The company remains debt-free with cash reserves of approximately…